- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features.
October 12, 2020
SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients.
October 12, 2020
Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma.
October 9, 2020
Interobserver Variability in Assessment of Renal Mass Biopsies.
October 9, 2020
Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry.
October 8, 2020
Comprehensive Review of Numerical Chromosomal Aberrations in Chromophobe Renal Cell Carcinoma Including its Variant Morphologies.
October 8, 2020
Targeting the HIF2-VEGF axis in renal cell carcinoma.
October 8, 2020
Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma.
October 7, 2020
TiNivo: Safety and Efficacy of Tivozanib-Nivolumab Combination Therapy in Patients with Metastatic Renal Cell Carcinoma.
October 6, 2020
The Role of Metabolic Factors in Renal Cancers.
October 6, 2020
Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment.
October 5, 2020
Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
October 5, 2020